# ğŸ§¬ Fluoroquinolone-Associated Cardiotoxicity in the UAE: NLP-Based Real-World Risk Analysis (2018â€“2025)

[![DOI](https://zenodo.org/badge/DOI/10.5281/zenodo.15271591.svg)](https://doi.org/10.5281/zenodo.15271591)

## ğŸ§  Introduction

This repository contains a reproducible analysis pipeline that investigates the cardiovascular risks associated with fluoroquinolone antibiotics in the UAE using a multi-modal AI framework. By combining natural language processing (NLP), pharmacovigilance reports, physician notes, and machine learning (ML), the study aims to:

- Assess adverse cardiac outcomes (QT prolongation, arrhythmias, sudden cardiac death)
- Analyze prescribing trends (2018â€“2025) using real-world and simulated UAE data
- Measure risk awareness among healthcare providers
- Predict high-risk cases using AI-based models

This work helps bridge the regional data gap and supports policy recommendations for safer prescribing practices.

---

## ğŸ“Š Results / Figures

### 1. Kaplanâ€“Meier Survival Analysis

This figure illustrates the time-to-onset of arrhythmia events stratified by fluoroquinolone type. Moxifloxacin demonstrates a steeper early drop, indicating faster onset in some patients.

![KM Curve](figures/km_arrhythmia_by_drug.png)

---

### 2. Logistic Regression (Odds Ratios)

Forest plot displaying adjusted odds ratios (OR) for arrhythmia risk by drug type and predisposing conditions. Moxifloxacin shows significantly increased adjusted risk.

![Logistic Regression](figures/logistic_odds_ratios_arrhythmia.png)

---

### 3. Arrhythmia Incidence by Fluoroquinolone Type

This bar chart compares the predicted probabilities of arrhythmia for each fluoroquinolone. Moxifloxacin ranked highest, followed by levofloxacin and ciprofloxacin.

![Arrhythmia Probability](figures/arrhythmia_probability_by_drug.png)

---

## ğŸ“‚ Project Structure

```plaintext
ğŸ“ data/
    â”œâ”€â”€ prescriptions_mohap_2018_2023.csv
    â”œâ”€â”€ faers_cardio_adrs_cleaned.csv
    â”œâ”€â”€ ehr_physician_notes_sample.csv
    â”œâ”€â”€ co_medication_interactions.csv
    â””â”€â”€ literature_guidelines_extracted.csv

ğŸ“ models/
    â”œâ”€â”€ fq_cardiac_risk_classifier.pkl
    â””â”€â”€ transformers_fine_tuned_ner_model/ (includes config.json, tokenizer.json, model.safetensors, etc.)

ğŸ“ results/
    â”œâ”€â”€ descriptive_statistics_summary.csv
    â”œâ”€â”€ risk_awareness_scores_by_provider.csv
    â”œâ”€â”€ time_trend_prescribing_2020_2025.csv
    â””â”€â”€ model_performance_metrics.json

ğŸ“ figures/
    â”œâ”€â”€ km_arrhythmia_by_drug.png
    â”œâ”€â”€ logistic_odds_ratios_arrhythmia.png
    â””â”€â”€ arrhythmia_probability_by_drug.png

ğŸ“ notebooks/
    â”œâ”€â”€ 01_data_cleaning_preprocessing.ipynb
    â”œâ”€â”€ 02_ner_and_sentiment_analysis.ipynb
    â”œâ”€â”€ 03_risk_prediction_model_training.ipynb
    â”œâ”€â”€ 04_kaplan_meier_and_logistic_regression.ipynb
    â””â”€â”€ 05_dashboard_visualization_powerbi.ipynb

## ğŸ“Š Interactive Dashboard

This interactive Power BI dashboard provides a real-time summary of fluoroquinolone prescribing patterns, risk signals, and ADRs across the UAE (2018â€“2023). It includes:
- Drug-specific arrhythmia risks
- High-risk co-prescription alerts
- Timeline-based prescribing trends

ğŸ”— [Open Dashboard in Power BI](https://yourpowerbi-public-url.com)

### ğŸ“· Static Preview

![Dashboard Overview](figures/dashboard_overview.png)


